Framingham Risk Score for Prediction of Cardiovascular Diseases: A Population-Based Study from Southern Europe

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Artigao Rodenas, Luis M ^a   Carbayo Herencia, Julio A ^b,c   Divisón Garrote, Juan A ^a   Gil Guillén, Vicente F ^d,e   Massó Orozco, Javier ^f   Simarro Rueda, Marta ^a   Molina Escribano, Francisca ^g   Sanchis, Carlos ^h   Carrión Valero, Lucinio ^a   López de Coca, Enrique ^a   Caldevilla, David ⁱ   López Abril, Juan ^a   Carratalá Munuera, Concepción ^d   Lopez Pineda, Adriana ^d  

^a Primary Health Care Centre   (Spain)

^b Medical Corps   (Spain)

^c UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^d MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^e Elda Hospital   (Spain)

^f Casas de Juan Núñez Primary Health Care Centre   (Spain)

^g Casas Ibáñez Primary Care Center   (Spain)

^h Primary Healthcare Centre   (Spain)

ⁱ Albacete   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ALGORITHM; ARTICLE; BLOOD PRESSURE; CALIBRATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HUMAN; MALE; PREDICTION; PREDICTIVE VALUE; RANDOM SAMPLE; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; SMOKING; SOUTHERN EUROPE; SPAIN; VALIDITY; VASCULAR AGE;

ADULT; AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROBABILITY; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SEX FACTORS; SPAIN;

EID: 84883504623     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073529     Document Type: Article

References (35)

1. Banegas JR, Rodríguez-Artalejo F, Graciani A, Villar F, Herruzo R, (2003) Mortality attributable to cardiovascular risk factors in Spain. Eur J Clin Nutr 57 (Suppl. 1) ():: S18-S21. doi:10.1038/sj.ejcn.1601804. PubMed: 12947446.
2. Menotti A, Lanti M, Puddu PE, Kromhout D, (2000) Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart. 84: 238-244. doi:10.1136/heart.84.3.238. PubMed: 10956281.
3. Fuster V, (2002) Applied Cardiological Research. Challenges for the New Millenium [Editorial] Rev Esp Cardiol 55: 327-332. doi:10.1016/S0300-8932(02)76609-8. PubMed: 11975897.
4. National Cholesterol Education Program (NECP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 106: 3143-3421. PubMed: 12485966.
5. Stone NJ, Bilek S, Rosenbaum S, (2005) Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options. Am J Cardiol 96 (Suppl.) ():: 53E-59E. doi:10.1016/j.amjcard.2005.09.030. PubMed: 16098845.
6. Mancia G, De Backer G, Dominiczak A, et al. (2007) Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25: 1105-1187. doi:10.1097/HJH.0b013e3281fc975a. PubMed: 17563527.
7. Clark AM, Hartling L, Vandermeer B, McAlister FA, (2005) Meta-analysis: secondary prevention programs for patients with coronary heart disease. Ann Intern Med 143: 659-672. doi:10.7326/0003-4819-143-9-200511010-00010. PubMed: 16263889.
8. McAlister FA, Lawson FM, Teo KK, Armstrong PW, (2001) Randomised trials of secondary prevention programmes in coronary heart disease: systematic review. BMJ 323: 957-962. doi:10.1136/bmj.323.7319.957. PubMed: 11679383.
9. Conroy RM, Pyörälä K, Fitzgerald AP, et al. (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24: 987-1003. doi:10.1016/S0195-668X(03)00114-3. PubMed: 12788299.
10. Assmann G, Cullen P, Schulte H, (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 105: 310-315. doi:10.1161/hc0302.102575. PubMed: 11804985.
11. Marrugat J, D'Agostino R, Sullivan L, et al. (2003) An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health. 57: 634-638. doi:10.1136/jech.57.8.634. PubMed: 12883073.
12. Aranceta J, Pérez Rodrigo C, Foz Sala M, et al. (2004) Tables of coronary risk evaluation adapted to the Spanish population: the DORICA study. Med Clin (Barc) 123: 686-691. doi:10.1016/S0025-7753(04)75331-2.
13. Anderson KM, Wilson PW, Odell PM, Kannel WB, (1991) An updated coronary risk profile. A statement for health professionals. Circulation 83: 356-362. doi:10.1161/01.CIR.83.1.356. PubMed: 1984895.
14. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, et al. (1998) Prediction of coronary heart disease using risk factor categories. Circulation. 97: 1837-1847. doi:10.1161/01.CIR.97.18.1837. PubMed: 9603539.
15. Menotti A, Puddu PE, Lanti M, (2000) Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 21: 365-370. doi:10.1053/euhj.1999.1864. PubMed: 10666350.
16. Brindle P, Emberson J, Lampe F, et al. (2003) Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ. 327: 1267-1272. doi:10.1136/bmj.327.7426.1267. PubMed: 14644971.
17. Rodondi N, Locatelli I, Aujesky D, Butler J, Vittinghoff E, et al. (2012) Health ABC Study. Framingham risk score and alternatives for prediction of coronary heart disease in older adults. PLOS ONE. 7(3):: e34287. doi:10.1371/journal.pone.0034287. PubMed: 22470551.
18. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 117: 743-753. doi:10.1161/CIRCULATIONAHA.107.699579. PubMed: 18212285.
19. Puras A, Sanchis C, Artigao LM, Divison JA, (1998) Prevalence, awareness, treatment, and control of hypertensión in a Spanish population. Eur J Epidemiol 14: 31-36. doi:10.1023/A:1007483916158. PubMed: 9517870.
20. Artigao M, López Abril J, Sanchis C, (1991) Patología circulatoria y factores de riesgo vascular en la Zon Básica de Salud III de Albacete. In: Gómez Ruiz FT, eds. Atención al paciente vascular en AP. Barcelona: Repro Disseny, S.L pp. pp. 53-65.
21. Divisón JA, Sanchís C, Artigao LM, et al. (1998). Prevalence of obesity and its relationship with cardiovascular risk in the population of Albacete. Aten Primaria 21: 205-12.
22. Rodríguez Paños B, Sanchís C, García Gosálvez F, et al. (2000) Prevalence of diabetes mellitus and its relationship with other risk factors in the population of Albacete. Aten Primaria 25: 84-97.
23. Hanley JA, McNeil BJ, (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 143(1):: 29-36. PubMed: 7063747.
24. Carbayo JA, Divisón JA, Escribano J, et al. (2007) Using ankle-brachial index to detect peripheral arterial disease: Prevalence and associated risk factors in a random population sample. Nutr Metab Cardiovasc Dis 17: 41-49. doi:10.1016/j.numecd.2005.08.009. PubMed: 17174225.
25. Banegas JR, Rodríguez-Artalejo F, Guallar-Castillón P, (2006) Current Epidemiology of Heart Failure in Spain. Rev Esp Cardiol 6 (Suppl.) ():: 4C-9C. doi:10.1157/13092028.
26. Warnick GR, Nguyen T, Albers AA, (1985) Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. Clin Chem 31: 217-222. PubMed: 2578337.
27. O'Donnell CJ, Elosua R, (2008) Cardiovascular Risk Factors. Insights From Framingham Heart Study. Rev Esp Cardiol 61: 299-310. doi:10.1157/13116658. PubMed: 18361904.
28. Collins GS, Altman D, (2009) An independent external validation of QRISK cardiovascular risk predictive: a prospective open cohort study. BMJ. 339: 2584-2593. doi:10.1136/bmj.b2584.
29. Marrugat J, Subirana I, Comín E, Cabezas C, Vila J, et al. (2007) Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study. J Epidemiol Community Health. 61: 40-47. doi:10.1136/jech.2005.038505. PubMed: 17183014.
30. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, et al. (2007) Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 335: 136. doi:10.1136/bmj.39261.471806.55. PubMed: 17615182.
31. Woodward M, Brindle P, Tunstall-Pedoe H, for the SIGN Group on Risk Estimation (2007) Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart. 93: 172-176. PubMed: 17090561.
32. Essink-Bot ML, Kruijshaar ME, Barendregt JJ, Bonneux LG, (2007) Evidence-based guidelines, time-based health outcomes, and the Matthew effect. Eur J Public Health 17: 314-317. doi:10.1093/eurpub/ckl238. PubMed: 17060334.
33. Berry JD, Liu K, Folsom AR, et al. (2009) Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the Coronary Artery Risk Development in Young Adults Study and Multi-Ethnic Study of Atherosclerosis. Circulation 119: 382-389. doi:10.1161/CIRCULATIONAHA.108.800235. PubMed: 19139385.
34. Marma AK, Lloyd-Jones DM, (2009) Systematic examination of the updated Framingham Heart Study general cardiovascular risk profile. Circulation 120: 384-390. doi:10.1161/CIRCULATIONAHA.108.835470. PubMed: 19620502.
35. Pencina MJ, D'Agostino RB Sr, Larson MG, Massaro JM, Vasan RS, (2009) Predicting the 30-year risk of cardiovascular disease: the Framingham Heart Study. Circulation 119: 3078-3084. doi:10.1161/CIRCULATIONAHA.108.816694. PubMed: 19506114.